The Impact Of Bmi And Gender Disparities On Nafld Among Young Adults
DOI:
https://doi.org/10.52783/jns.v14.2828Keywords:
Non- alcoholic fatty liver disease, Risk factors, gender disparities, young adults, co-morbiditiesAbstract
Background: Non-alcoholic fatty liver disease (NAFLD) is an abnormal buildup of fat in the liver, which can lead to inflammation and cirrhosis. The purpose of this study was to determine the prevalence of NAFLD in teenagers and how it related to clinical and biochemical markers.
Objective: The purpose of this research was to find out the prevalence of non- alcoholic fatty liver disease among young adults.
Method: This cross-sectional analytical investigation was carried out in Puducherry. The study included males and females who provided informed consent and fulfilled inclusion criteria. Between the ages of 18 -35, 100 non-alcoholic persons (male and female) participated in the study all subjects had ultrasonography to rule out fatty liver. SPSS software version 22.0 was used to statistically evaluate all of the results.
Result: Overall, 71% of male had NAFLD and 29% of female had NAFLD. Men are more likely than female to acquire NAFLD. The Ultrasonogram's fatty liver grading system showed that 40.2% of participants had grade 1, 20.8% had grade 2, and 0.5% had grade 3. Overweight were more likely than Normal weight to acquire NAFLD in this study, which covered both sexes. According to this study, NAFLD affected 36.4% of Normal weight and 63.6% of Overweight.
Conclusion: Therefore, co-morbidities, risk factors, and gender inequities all have a substantial impact on the development of NAFLD. Males in particular who are overweight are more likely to get the NAFLD. Co-morbidities, like BMI, are important in development of NAFLD. NAFLD and its effects may be lessened if these risk factors are addressed with targeted interventions.
Downloads
References
Li W, Ng CH, Quek J, Chan KE, Tan C, Zeng RW, et al. The growing prevalence of non-alcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States: A 20-year experience. Metab Target Organ Damage. 2022 Nov 2;2(4):N-A.
Mehreen TS, Harish R, Kamalesh R, Anjana RM, Mohan V. Non-alcoholic fatty liver disease in Asian Indian adolescents and young adults: Prevalence and its associated risk factors. J Diabetol. 2021 Apr–Jun;12(2):218-23. doi: 10.4103/jod.jod_104_20.
Temple JL, Cordero P, Li J, Nguyen V, Oben JA. A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int J Mol Sci. 2016;17(6):947. doi: 10.3390/ijms17060947.
Deurenberg P, Deurenberg‐Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev. 2002;3(3):141-6.
Moran JR, et al. Steatohepatitis in obese children: A cause of chronic liver dysfunction. Am J Gastroenterol. 1983;78(6).
Dasarathy S, et al. Validity of real-time ultrasound in the diagnosis of hepatic steatosis: A prospective study. J Hepatol. 2009;51(6):1061-7.
Alisi A, et al. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment. Ann Med. 2012;44(1):29-40.
Jain V, Jana M, Upadhyay B, Ahmad N, Jain O, Upadhyay AD, et al. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents. Indian J Med Res. 2018 Sep;148(3):291-301. doi: 10.4103/ijmr.IJMR_1966_16.
Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. 2016 Jan-Mar;60(1):26-33. doi: 10.4103/0019-557X.177295.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431.
Kalra S, Vithalani M, Gulati G, Kulkarni CM, Kadam Y, Pallivathukkal J, et al. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India. 2013 Jul;61(7):448-53. PMID: 24772746.
Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, et al. Prevalence of non-alcoholic fatty liver disease: Population-based study. Ann Hepatol. 2007 Jul-Sep;6(3):161-3. PMID: 17786142.
Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. 2016 Jan-Mar;60(1):26-33. doi: 10.4103/0019-557X.177295. PMID: 26911214.
Gerstenmaier JF, Gibson RN. Ultrasound in chronic liver disease. Insights Imaging. 2014;5:441–55.
Estes C, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123-33.
Wong SW, Chan WK. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian J Gastroenterol. 2020;39(1):1-8.
Grundy SM, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735-52.
Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862-73.
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018 Jan;67(1):328-57. doi: 10.1002/hep.29367. PMID: 28714183.
Li AA, Ahmed A, Kim D. Extrahepatic manifestations of nonalcoholic fatty liver disease. Gut Liver. 2020 Mar 15;14(2):168-78. doi: 10.5009/gnl19069. PMID: 31195434; PMCID: PMC7096231.
Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol. 2020 Apr 5;5:16. doi: 10.21037/tgh.2019.09.08. PMID: 32258520; PMCID: PMC7063528.
Niaz A, et al. Prevalence of NAFLD in healthy and young male individuals. Int Sch Res Notices. 2011;2011:363546.
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology. 2023 Apr;77(4):1335-47.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
